Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
The latest update is out from Koninklijke Philips ( (PHG) ).
Philips reported its 2024 Q4 results on February 19, 2025, showcasing a steady performance in challenging market conditions. The company achieved a 1% growth in both sales and order intake for the year, despite a significant decline in Chinese demand. Income from operations reached EUR 529 million for 2024, with an adjusted EBITA margin improvement to 11.5%. Notable achievements include the finalization of settlements related to the Philips Respironics recall in the US and maintaining a proposed dividend of EUR 0.85 per share. Philips also highlighted significant innovation efforts, including FDA clearances for new CT technologies and strategic collaborations to enhance diagnostic solutions, positioning itself strongly in the health technology sector.
More about Koninklijke Philips
Koninklijke Philips N.V., known as Royal Philips, is a diversified technology company primarily engaged in health technology. It offers a wide range of products and solutions across its Diagnosis & Treatment, Connected Care, and Personal Health segments, focusing on delivering innovative healthcare solutions and improving patient outcomes globally.
YTD Price Performance: 12.85%
Average Trading Volume: 572,558
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $26.36B
Learn more about PHG stock on TipRanks’ Stock Analysis page.
